Nanoparticles that combine features of viral and nonviral vectors show promise for targeted gene delivery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Niidome, T. & Huang, L. Gene Ther. 9, 1647–1652 (2002).
Yamada, T. et al. Nat. Biotechnol. 21, 885–890 (2003).
Kuroda, S., Otaka, S., Miyazaki, T., Nakao, M. & Fujisawa, Y. J. Biol. Chem. 267, 1953–1961 (1992).
Neurath, A.R., Kent, S.B., Strick, N. & Parker, K. Cell 46, 429–436 (1986).
Yamada, T. et al. Vaccine 19, 3154–3163 (2001).
Hunter, E. in Fields Virology, vol. 1 (eds. Knipe, D.M. & Howley, P.M.) 171–197 (Lippincott Williams & Wilkins, Philadelphia, 2001).
Vijayanathan, V., Thomas, T. & Thomas, T.J. Biochemistry 41, 14085–14094 (2002).
Peng, K.W. & Russell, S.J. Curr. Opin. Biotechnol. 10, 454–457 (1999).
Kao, J.H. & Chen, D.S. Lancet Infect. Dis. 2, 395–403 (2002).
Kneuer, C. et al. Bioconjug. Chem. 11, 926–932 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Russell, S. Rise of the nanomachines. Nat Biotechnol 21, 872–873 (2003). https://doi.org/10.1038/nbt0803-872
Issue Date:
DOI: https://doi.org/10.1038/nbt0803-872